ProCE Banner Events

Share

Myelofibrosis Expert Roundtable: State-of-the-Art Clinical Advances and Therapeutic Strategies From JAK Inhibition into the Future

Join us for this case-based, interactive, CME-certified live symposium at ASCO 2024 featuring expert perspectives and roundtable discussions of contemporary treatment for patients with myelofibrosis. Bring your questions for the live question and answer sessions with the expert panel.

Not an official event of the 2024 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation.

Physicians: maximum of 1.50 AMA PRA Category 1 Credits™

Who Should Attend

This program is intended for medical oncologists and other healthcare professionals who treat patients with myelofibrosis.

Time and location

Friday, May 31, 2024

6:30 PM - 8:30 PM Central Time (CT)

In-person

7:00 PM - 8:30 PM Central Time (CT)

Virtual

Hilton Chicago
720 S Michigan Ave
Chicago, Illinois 60605

Salon A 3-4, Lower Level

Agenda

  • State of the Union in Myelofibrosis Care
  • Selecting Initial Treatment for Patients With Myelofibrosis
  • Therapy in the Second Line and Beyond: Disease Progression or Intolerance to Initial Therapy
  • A Look to the Future: Novel Agents and Combination Therapy
  • Audience Question and Answer Session

Location

Venue Name

Hilton Chicago

Address

Hilton Chicago
720 S Michigan Ave
Chicago, Illinois 60605

Room Name

Salon A 3-4, Lower Level

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Myelofibrosis.

Target Audience
This program is intended for medical oncologists and other healthcare professionals who treat patients with myelofibrosis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Select the optimal JAK inhibitor or JAK inhibitor- based combination considering disease and patient-specific factors, available data and expert recommendations

  • Develop evidence-based second-line therapeutic strategies for patients with MF who are relapsed, refractory, or intolerant to prior JAK inhibitor therapy

  • Plan therapeutic strategies for patients with myelofibrosis and moderate to severe anemia

  • Evaluate available clinical data and expert perspectives on agents and combination regimens that improve constitutional symptoms, splenomegaly and cytopenias associated with myelofibrosis

  • Explain new data on emerging agents to educate colleagues and counsel patients regarding ongoing trial opportunities in myelofibrosis

Accreditation

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport 

 

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account. 

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from GlaxoSmithKline.

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.